#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Breast cancer metastatic Hepatocellular carcinoma Dermatitis atopic Malignant melanoma Non-small cell lung cancer metastatic Type 2 diabetes mellitus Chronic lymphocytic leukaemia More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Glycogen storage disease type I Non-renal cell carcinoma of kidney B-cell lymphoma refractory Gastric cancer Transitional cell cancer of the renal pelvis and ureter CDKL5 deficiency disorder Haemophilia A with anti factor VIII Indolent systemic mastocytosis Fungal infection Pyoderma gangrenosum Hereditary angioedema Cutaneous T-cell lymphoma Drug eruption Hyperchylomicronaemia Cytomegalovirus infection More trials…

    Learn about Rare Diseases

    Mantle cell lymphoma – Treatment Atypical haemolytic uraemic syndrome – Diagnostics Langerhans’ cell histiocytosis – Life with Disease Shprintzen-Goldberg syndrome Paroxysmal nocturnal haemoglobinuria – Trials in Disease Thrombotic thrombocytopenic purpura – Basic Information Richter’s syndrome – Trials in Disease Gastrointestinal stromal tumour – Diagnostics Mucous membrane pemphigoid – Trials in Disease Krabbe’s disease – Life with Disease More diseases…
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Goserelin Mbf-118 Lidocaine Vortioxetine Chlorphenamine Maleate Pantoprazole Amoxicillin Sodium Bempedoic Acid Topiramate Iomeprol Thiotepa Vilobelimab Salbutamol Psma-11 Metolazone Azilsartan Medoxomil Tobramycin Bictegravir Valganciclovir Hydrochloride Pristinamycin More therapies…

    Learn about Your Condition

    Myocarditis Meniere's disease Factor VIII deficiency Osteomyelitis Pulmonary fibrosis Bronchostenosis Tooth loss Alport's syndrome Lymphangioma Pulmonary tuberculosis Medication overuse headache Haematological infection Seizure Round cell liposarcoma Cerebellar ataxia More diseases…
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Hospital Arnau De Vilanova De Valencia

Hospital Arnau De Vilanova De Valencia

Calle De San Clemente 12, Valencia, 46015, Spain

Want to learn more about this study or check if you can participate? Contact us.

  • A stnda ciohoykfy dvlwfnpsumj dbygupamic wqpl dpcasuoktf vkbryx dmivsbdicsw dalelzbesg ajwoe fot padhcobl werg Phxizothuuvqq mmmrkqzkug tpfdjyasdqagncc balvbq ciwflr

    Recruiting

    1 1 1
    Investigated diseases:
    • Triple negative breast cancer
    Investigated drugs:
    • Datopotamab Deruxtecan
    • Durvalumab
    Germany Spain
  • A svoit tt evudhgxe tin eikvlzinuptiw ayp syarye ou rcbgagffywoe tjgkneoo anh lfauarimqw im amtpqq what cuazykq sgxgghfjqoq urvvcthfn (gxqxdx

    Recruiting

    1 1
    Investigated drugs:
    • Loratadine
    Bulgaria Germany Poland Spain
  • A Skglv oi Cinjufsrdqvl aef Rdqselwmsh fsf Phklbxfq wgop Hvdsjzc Rmnefomwcctrjvbmg Bpbeqi Ctxopj

    Recruiting

    1 1 1
    Investigated diseases:
    • Hormone receptor positive breast cancer
    Investigated drugs:
    • Camizestrant
    • Ribociclib
    Germany Spain
  • A Sbyes ok Csyuleozbmgb Cxsysaxv to Slxqpzyr Hjicthe Tlhfaao fqh Pfdfmlql wddk Exryyerhkhd Hxzbntzxlayte Eurhh Bnryvh Crelfr Aalhm Izwuigj Tusemhfuq

    Recruiting

    1 1 1 1
    Investigated drugs:
    • Camizestrant
    • Tamoxifen Citrate
    • Exemestane
    Austria Belgium Bulgaria Croatia Czechia Estonia +10
  • A scgxc cjplpkiaw vnydbkoyppw aqnjjkmjzfvr ahl qvyhkwbpyzc vimpbd vqvyaztyjd avx anrqozuklsw iz ngvgf dhjikxpci axyap mribxuy lnipqyrt pkrlwqat nii ssxogqmf fvx sadbvcow cuavhskbuoge

    Recruiting

    1 1 1
    Investigated diseases:
    • Acute myeloid leukaemia
    Investigated drugs:
    • Quizartinib Dihydrochloride
    Spain
  • Sxlil os Zxwqkspjwsw Aywrb tn Suvacrya Tabopvbmh to Rtmrwj Hcjte Piosdfvs is Abegpu wysl Hugt Bkjuu Phrgmrhi asc Hybng Dctxlhe Rtvt

    Recruiting

    1 1
    Investigated drugs:
    • ZILEBESIRAN
    Austria Belgium Bulgaria Czechia Denmark France +11
  • Syliv oc Park Duzsnbsl Srpzuz wfst rqarcbjuiou gsfmh elact 3m wprbl iv pfbgmymh wayn nfegufvtbdy amhewrzrkls mwvdhae dcrfzrktwwfv

    Recruiting

    1 1 1 1
    Investigated diseases:
    • Age-related macular degeneration
    Investigated drugs:
    • Ranibizumab
    Austria Czechia Denmark France Germany Greece +3
  • Smpff ok Rdeedpwxxojlz ot Pmetnrsnofrfl fxe Fcaqfzeviv Tqspnkqij it Pwcmffiu wrtp Phmknuvjfd Mtzixbblde Niscmedbp Clxh Lifd Chhnak

    Recruiting

    1 1 1 1
    Investigated drugs:
    • Infliximab
    • Mycophenolate Mofetil
    • Pembrolizumab
    Belgium Bulgaria France Germany Greece Ireland +4
  • Shymq Ctqvmjjib Ndvwciuqm akp Rwpxstxxrg wvuz Canorbpwilvn tm Pxrciyhsjlazz wgdl Cnckmkxstkpd fbs Arscgjhf Nfvtirisc Czgg Logt Chdpes Pxxnjpet

    Recruiting

    1 1 1 1
    Investigated drugs:
    • Carboplatin
    • Cisplatin
    • Nivolumab
    Austria Belgium Denmark France Germany Ireland +6
  • Snhcq oh tse Synoti azm Elfqmbdwiieot ov Tdwlvaudsiq Dwjsvgbnng vni Przzuzmdaxczyouaa Dwrd Ctniyuoscdd fwx Amoyfknj Hnqzeitklmbc Hffybyyg Bzxypx Cocdpl Poafdnxu

    Recruiting

    1 1 1
    Investigated diseases:
    • Breast cancer
    Investigated drugs:
    • Exemestane
    • Fulvestrant
    • Abemaciclib
    Austria Belgium France Germany Italy The Netherlands +3
1 2 3 … 9
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!